Mizusawa Yuka | Department Of Cardiology Tokyo Metropolitan Hiroo General Hospital

スポンサーリンク

概要

関連著者

もっと見る

著作論文

PJ-020 Electrophysiological Characteristics of Bundle Branch Reentrant Ventricular Tachycardia and Interfascicular Ventricular Tachycardia(PJ004,Arrhythmia, Others (Clinical/Diagnosis/Treatment) 8 (A),Poster Session (Japanese),The 73rd Annual Scientific M
PJ-287 Prognosis and Complication of ICD Implantation in Asymptomatic Brugada Syndrome(PJ048,Arrhythmia, Others (Clinical/Diagnosis/Treatment) 3 (A),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
FRS-081 Successful Percutaneous Coronary Intervention (PCI) Shows Long-term Antiarrhythmic Effects in Patients with Acute Coronary Syndrome (ACS)(FRS17,Novel Approaches to Treatment of CAD (IHD),Featured Research Session (English),The 73rd Annual Scientif
Bidirectional Ventricular Tachycardia Caused by a Reentrant Mechanism With Left Bundle Branch Block Configuration on Electrocardiography
PE-258 Impact of Simultaneous Block Line on Development of Atrial Tachycardia after Extensive Encircling Pulmonary Vein Isolation(Arrhythmia, therapy(08)(A),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
OJ-057 Catheter Ablation for Ventricular Tachycardias in Reduction of Frequent Discharges of Implantable Cardioverter-Defibrillator in Patients with Old Myocardial Infarction(Arrhythmia, therapy(06)(A),Oral Presentation(Japanese),The 72nd Annual Scientifi
PJ-447 Does 2.25mm Bare Metal Stent Implantation for Very Small Vessel Have a Better Prognosis Compared to the Prognosis of POBA?(Coronary revascularization, PCI(20)(IHD),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulat
Effects of Bepridil and Amiodarone for Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation Compared to Na Channel Blockers
Significance of Plasma Brain Natriuretic Peptide in Patients with Reversible Left Ventricular Dysfunction takotsubo Cardiomyopathy
Effects of Quinidine and Aminophyline for Prevention of Ventricular Fibrillation (VF) Induction in Patients with Brugada Syndrome
Clinical Evaluation of Takotsubo Cardiomyopathy, a Reversible Form of Left Ventricular Dysfunction, with ^I-MIBG Myocardial Scintigraphy
Efficacy of Rhythm Control for Persistent/Paroxysmal Atrial Fibrillation by Antiarhythmic Drugs with ACE Inhibitors or Angiotensin II Receptor Blockers (Arrhythmia, Pharmacological Therapy 6 (A), The 69th Annual Scientific Meeting of the Japanese Circulat
Usefulness of Late Potential from Signal-averaged Electrocardiogram for Risk Stratification in the Brugada Syndrome(Arrhythmia, Diagnosis/Pathophysiology/EPS 9 (A), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
OJ-452 Preventive effect for recurrence of atrial fibrillation by Bepridil in patients with low left atrial appendage function.(Arrhythmia, Pharmacological Therapy 5 (A) : OJ55)(Oral Presentation (Japanese))
OJ-428 Reevaluation of Late Potential as a New Predictor of Life Threatening Cardiac Arrhythmias in the era of percutaneous cardiac intervention(ECG/Body Surface Potential Mapping/Holter 6 (A) : OJ52)(Oral Presentation (Japanese))
OJ-231 Effects of Isoproterenl and Anti-arrhythmic Drugs for Prevention of Atrial Fibrillation Induction in Patients with Brugada Syndrome(Arrhythmia, Diagnosis/Pathophysiology/EPS 9 (A) : OJ27)(Oral Presentation (Japanese))
Effect of Cigarette Smoking on the Risk of Atrial Fibrillation Recurrence after Pulmonary Vein Isolation
OJ-254 Daily variation of ST-segment elevation on 12 lead ECG in the Brugada syndrome(ECG/Body Surface Potential Mapping/Holter 3 (A) : OJ30)(Oral Presentation (Japanese))
OJ-232 New provocation test in ST-segment elevation in the Brugada syndrome : Diagnostic criteria on ECG during oral glucose tolerance test (OGTT-ECG)(Arrhythmia, Diagnosis/Pathophysiology/EPS 9 (A) : OJ27)(Oral Presentation (Japanese))
Risk Determinants in Individuals With a Spontaneous Type 1 Brugada ECG
Seasonal and Circadian Distributions of Cardiac Events in Genotyped Patients With Congenital Long QT Syndrome
Carvedilol, a Non-Selective β-with α_1-Blocker is Effective in Long QT Syndrome Type 2
Mutations of the Cardiac Ryanodine Recepter (RyR2) Gene in Catecholaminergic Polymorphic Ventricular Tachycardia
Genetic Background of Catecholaminergic Polymorphic Ventricular Tachycardia in Japan
Genetic Background of Catecholaminergic Polymorphic Ventricular Tachycardia in Japan

もっと見る

スポンサーリンク